期刊文献+

探讨光稳定性试验在上市药品质量标准研究中的应用

Application on photostability Experiment for the Revaluation of Postmarketing Drug Standards
下载PDF
导出
摘要 目的:探讨光稳定性试验在上市药品质量标准研究的应用。方法:按照ICH药物光稳定性试验指导原则,依据盐酸洛美沙星的质量标准,考察光强制破坏条件下,盐酸洛美沙星原料、片剂和胶囊剂的稳定性及其盐酸洛美沙星溶液的光降解动力学。结果:经HPLC检测可知,原料、片剂和胶囊剂直接光照15 d,固体样品主成分基本稳定;原料、片剂和胶囊剂的溶液光照24 h不稳定,有杂质产生;溶出度测定溶液光照24 h,降解动力学拟合符合0.5级动力学方程;含量测定供试品溶液光照24h,降解动力学拟合符合1级动力学方程。结论:光稳定性试验不仅可用于上市前的药品评价,亦可为上市药品质量标准研究提供数据支持。 Objective: To investigate the application of photostability experiment to the revaluation of postmarketing drug stand- ards. Methods: According to the ICH principles of photostability and the quality standard of Lomefloxacin Hydrochloride, the stability of raw materials, tablets and capsules, as well as the photodegradation of Lomefloxacin Hydrochloride solution were in- spected. Results: HPLC tests showed : the main constituents of solid samples, such as raw materials, tablets and capsules which were directly illuminated for 15 days, were basically stable; the samples of aqueous solution, which were illuminated for 24 hours, were not stable and there was impurity produced in it. The photodegradation of the dissolution solution which was illumi- nated for 24 hours followed the 0.5-order kinetics ; the test solution of assaying under the determination followed the first-order ki- netics. Conclusion: Photostability experiment can not only be used for the evaluation of drugs before listing, but also can provide data support for the revaluation of listed drug standards.
作者 孔爱英 刘成红 高锦 田增光 桑志红 Kong Aiying Liu Chenghong Gao Jin Tian Zengguang Sang Zhihong(Institute for Drug and Instrument Control , De- partment of Health, the Central Military Commission of the Central Military Commission, Beijing 100166 National Central of Biomedical Analysis, Bei- ring 100850)
出处 《中国药品标准》 CAS 2016年第6期430-433,共4页 Drug Standards of China
关键词 光稳定性试验 盐酸洛美沙星 光降解动力学 photostability experiment Lomefloxacin Hydrochloride photodegradation kinetics
  • 相关文献

参考文献3

二级参考文献37

  • 1[1]ICH Harmonized Tripartite Guideline, Stability Testing of New Drug Substances and Products. 27 October 1993
  • 2[2]S. Yoshioka,Y. Ishihara,et al, Quinine actinometry as a method for calibrating ultraviolet radiation intensity in light stability testing of pharmaceuticals. Drug Dev. Ind. Pharm. 20, 2049 ~ 2062(1994)
  • 3[3]R. teraoka and Y. Matsda,Stabilization orieanted preformulation study of photolabile menatetrenone. Int. J. Pharm, 93,85 ~ 90(1993).
  • 4[4]Beno-P, Gasparic-J, Drug stability studies Cesk-Farm, 42(may)203~211(1993).
  • 5[5]Piechocki-JT,Wolters-RJ,Light Stability studies :misnomer Pharm-Technol, 18 (Jan), 60,62,64 ~ 65 ( 1994 ).
  • 6[6]Caporal-Gautier-J, Stability and ICH, STP-Pharma-Pratiqies,3(5),346~347(1993).
  • 7[7]ICH Harmonized Tripartite Guideline,Stability Testing Photostability testing of New Drug Substances and Products. 23 November 1996.
  • 8[9]T. Mizuno,M. Hanamori,K. Akimoto,H. Nakagawa and K.Arakaana, Wavelength dependency and mechanism of the photodegradation of ethly 2-[ 4, 5-bis (4-methoxyphenyl) thiazole-2-yl]pyrrol-l-ylacetate (KBT-3022)in solution, Chem. Pham. Bull, 42,160~162(1994).
  • 9[10]G. S. Sadana and A. B. Ghogare, Mechanistic studies on photolytic degration of nifedipine by use of 1H-NMR and13C-NMR spectroscopy,Int. J. Pharm. 70,195~199(1991).
  • 10[13]Matso. M,Effects of light sources on photostability testing,Drug Stability, 1 (3), 179~ 187 (1996).

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部